Xenetic Biosciences
XBIO
10 hedge funds and large institutions have $184K invested in Xenetic Biosciences in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
11% more funds holding
Funds holding: 9 → 10 (+1)
0.39% less ownership
Funds ownership: 4.16% → 3.77% (-0.39%)
27% less capital invested
Capital invested by funds: $250K → $184K (-$66.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$13.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.62K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$672 |
| 4 |
AIP
Alexis Investment Partners
Montgomery,
Texas
|
+$82 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGF
LGT Group Foundation
Vaduz,
Liechtenstein
|
-$41.1K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $90.9K | +$13.7K | +4,200 | +17% |
|
|
S
2
Sachetta
Lynnfield,
Massachusetts
| $47.9K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $34.2K | +$672 | +206 | +2% |
|
|
JEST
4
JTC Employer Solutions Trustee
St Helier,
Jersey
| $9K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.56K | +$1.62K | +497 | New |
|
|
AIP
6
Alexis Investment Partners
Montgomery,
Texas
| $79 | +$82 | +25 | New |
|
|
7
Bank of America
Charlotte,
North Carolina
| $38 | -$3 | -1 | -8% |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $16 | – | – | – |
|
9
Morgan Stanley
New York
| $12 | – | – | – |
|
|
DWM
10
Darwin Wealth Management
Tampa,
Florida
| $6 | – | – | – |
|
|
LGF
11
LGT Group Foundation
Vaduz,
Liechtenstein
| – | -$41.1K | -11,000 | Closed |
|
XBIO Hedge Fund Activity: Q3 2025 in Review
10 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q3 2025, worth a combined $184K — down 27% from $250K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new XBIO positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $13.7K. The largest seller was LGT Group Foundation, exiting entirely with an estimated $41.1K sold.
- 10 institutional investors held Xenetic Biosciences (XBIO) as of Q3 2025, up from 9 in Q2 2025.
- Funds reported $184K of Xenetic Biosciences stock for Q3 2025, down 27% quarter-over-quarter.
- 2 funds opened new Xenetic Biosciences positions in Q3 2025 and 1 closed out, a net change of +1 holder.
- The largest Xenetic Biosciences buyer in Q3 2025 was Renaissance Technologies, an estimated $13.7K added.
- The largest Xenetic Biosciences seller in Q3 2025 was LGT Group Foundation, an estimated $41.1K sold.
Based on aggregated 13F filings for Q3 2025.